Bitcoin

The crypto market is currently in a fear-driven, low-volume environment (Fear & Greed 27, BTC dominance high) where altcoins are underperforming. Scientific breakthroughs in aging are a long-tail macro theme that could shift institutional interest toward biotech ETFs or longevity tokens, but only if they reach clinical validation. For now, this is a non-event for crypto pricing.

Nature publishes study on mitochondrial metabolism and epigenetic crosstalk driving SASP, highlighting SLC25A1 inhibition as a potential therapeutic target for delaying age-related decline.